Liver tissue biopsy allows for the assessment of steatosis, inflammation, and fibrosis to determine staging of disease. It should be noted that for the NASH indication, liver biopsies represent the required regulatory endpoint.
Liver tissue biopsy allows for the assessment of steatosis, inflammation, and fibrosis to determine staging of disease. It should be noted that for the NASH indication, liver biopsies represent the required regulatory endpoint.
